Healthtech

Patricia Lay
Head of Life Sciences & Cosmetics Projects
Patricia Lay began her career with Inserm transfert Initiative (investment fund) and AstraZeneca (pharmaceutical laboratory) prior to joining (in 2013) the largest competitiveness cluster for health in France: Eurobiomed. With a background in Health sceince, AI applied to Health and Business and a graduate of the ESSEC, today she works as the Health Tech Team Côte d’Azur Expert.

tél. + 33 (0)4 92 17 51 85
mob. + 33 (0)6 26 31 21 49
mail. play@teamcotedazur.fr

HEALTHTECH EXPERTISE

PHARMA & BIOTECH
Diseases linked to aging are opening up new areas of investigation for academic researchers, as well as for manufacturers, who find on the French Riviera, given the demographic pyramid and the high concentration of practitioners and researchers, an ideal location for combining basic research, clinical trials and experiments.
The French Riviera thus enables local stakeholders to trial their technology on a population representative of France as a whole and Europe in ten years’ time.
The French Riviera boasts a growing number of specialist areas in various diseases:
Infectiology/Oncology/Microbiology/Neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease)/Dermatology/Cell therapy/Diabetes

Innovation in life sciences is supported by public research divided into centres of excellence around the Institute of Molecular and Cellular Pharmacology (IPMC), the Mediterranean Centre for Molecular Medicine (C3M), the Valrose Institute of Biology (IBV), the Research Institute on Cancer and Aging (IRCAN), the Antoine Lacassagne Centre, the Nice Chemistry Institute and the French National Institute for Research in Computer Science and Automation (INRIA) (Therachon, spin off from the university acquired in 2019 by Pfizer for 340M$).
/ Presence of the largest competitiveness hub in France and ranked among the best in the Eurobiomed cluster: 172 R&D projects representing 718 million euros investment and 700 direct jobs.
/ 1 faculty of medicine with 5 mixed clinical resarch units
/Cardio-respiratory physiology: CARRES

  • Immuno-transplantation: INNOVANT
  • Movement: IULS
  • Pain: PIN
  • Imaging: URRIS

SPECIALITIES

AI

E-health

Pharma biotech

KEY FIGURES

2nd

sector on the French Riviera

3,1 Mds

in turnover

11 330

jobs

313

Establishments

2nd

in France for clinical research

15

Academic research teams

300

AI researchers

7

AI masters

  • CASE STUDY

    Relocalisation of a Parisian biotech company to the French Riviera: Phenocell

    AIM

    Identify potential partners to develop activity with manufacturers and academic KOLs

    Find premises with a Type L2 laboratory

    Research local financial assistance possibilities

    Provide support to directors to help convince employees to accept professional mobility

    OUR MISSION

    Identify and contact with potential partners on the French Riviera

    Look for premises measuring several hundred m², with office space and the possibility to create a laboratory

    Assessment and refinement of the Business Plan

    Access to events (IPEM, etc.)

    Contact with the public and private local ecosystem

    Communication and set up

    RESULT

    Maturation of the project within 3 years
    Set-up of the company on the French Riviera
    Support from half of all employees

They're on the French Riviera